主页 > 医学动态 >
【drug-news】精神分裂症药物证明对自闭症有效
Sunday Oct 8 08:31 AEST
A schizophrenia drug won US approval as the first medicine to treat symptoms of autism in children and adolescents, the Food and Drug Administration said on Friday.
The FDA said Johnson & Johnson's Risperdal could be used to treat irritability, including aggression, deliberate self-injury and temper tantrums.
Autism is a term used to describe a broad range of symptoms, from repetitive behaviours to trouble with language and sometimes mental retardation.
Risperdal is already Johnson & Johnson's biggest-selling product, with 2005 global sales of about $3.5 billion.
[被屏蔽广告]
[被屏蔽广告]
[被屏蔽广告]
The FDA said it based the new approval on two eight-week studies in 156 autistic patients ages 5 to 16 who took Risperdal or a placebo. Ninety-per cent of them were between the ages of 5 to 12.
Patients treated with Risperdal had improved scores on two scales measuring behavioural symptoms, the FDA said.
The Centers for Disease Control and Prevention estimated in May that autism affected up to one in every 175 children. That would mean at least 300,000 US school children have autism.
Johnson & Johnson said Risperdal does not treat core autism symptoms such as communication problems and trouble with social interactions, but "it has been shown to be beneficial in treating the associated behavioural disturbances that can interfere with school, learning and family life."
Risperdal, an oral drug, has been sold since 1993 for the short-term treatment of adults with schizophrenia. It was approved in 2003 for short-term treatment of adults with bipolar mania. The most common side effects include drowsiness, constipation, fatigue and weight gain. 认领。。 Schizophrenia drug approved for autism
精神分裂症药物批准用于孤独症
Sunday Oct 8 08:31 AEST
A schizophrenia drug won US approval as the first medicine to treat symptoms of autism in children and adolescents, the Food and Drug Administration said on Friday.
FDA星期五称，精神分裂症药物是第一类获准用于治疗儿童和青少年孤独症的药物。
The FDA said Johnson & Johnson's Risperdal could be used to treat irritability, including aggression, deliberate self-injury and temper tantrums.
FDA称，强生公司的利培酮能用于治疗易激惹，包括包括攻击行为，蓄意自伤和发脾气。
Autism is a term used to describe a broad range of symptoms, from repetitive behaviours to trouble with language and sometimes mental retardation.
易激惹是一种症状范围的描述，从重复性动作到语言障碍和有时智力迟钝。
Risperdal is already Johnson & Johnson's biggest-selling product, with 2005 global sales of about $3.5 billion.
利培酮已经是强生公司的拳头产品，2005年全球销售额为3.5亿美元。
The FDA said it based the new approval on two eight-week studies in 156 autistic patients ages 5 to 16 who took Risperdal or a placebo. Ninety-per cent of them were between the ages of 5 to 12.
FDA称，新适应症的批准基于两个为期8周的研究结果，156个5至16岁的易激惹的患者服用利培酮或安慰剂，90%的患者年龄在5至12岁。
Patients treated with Risperdal had improved scores on two scales measuring behavioural symptoms, the FDA said.
服用利培酮治疗的患者已经在两项行为症测试的分值得到了改善。
The Centers for Disease Control and Prevention estimated in May that autism affected up to one in every 175 children. That would mean at least 300,000 US school children have autism.
疾病预防控制中心在五月份评估了受易激惹影响的儿童，每175儿童就有一个受其影响。在美国至少有3000000儿童患有易激惹。
Johnson & Johnson said Risperdal does not treat core autism symptoms such as communication problems and trouble with social interactions, but "it has been shown to be beneficial in treating the associated behavioural disturbances that can interfere with school, learning and family life."
强生公司说，利培酮不能治疗易激惹核心症状，如社交障碍，但他已经表明对治疗与干扰学校、学习和家庭生活有关的行为有益。
Risperdal, an oral drug, has been sold since 1993 for the short-term treatment of adults with schizophrenia. It was approved in 2003 for short-term treatment of adults with bipolar mania. The most common side effects include drowsiness, constipation, fatigue and weight gain.
利培酮，口服药物，1993批准用于成人精神分裂的短期治疗。2003年批准用于双相成人精神分裂症的短期治疗。最常见的不良反应为：困倦，便秘，疲劳和体重增加。 [标签:content1][标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-03-01 17:12
医学,生命科学网